About Transfection Technology
Transfection technology is used for the introduction of nucleic acids into desired cells. The process enables the expression of desired proteins in efficient cells. A stable transfection enables the integration of this foreign nucleic acid into the cellular DNA resulting in the expression of the desired proteins in cell lines. The process, which can be accomplished by various physical, chemical, or viral methods, can be used for potential applications such as gene therapy, protein production, and drug discovery.
TechNavio's analysts forecast the Global Transfection Technologies market to grow at a CAGR of 8.71 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects and future prospects of the Global Transfection Technologies market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of different methods used in transfection inclusive of various instruments, reagents, and accessories which are used independently or as kits used for transfection.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Transfection Technologies market. In addition, the report discusses the major drivers that influence the growth of the market. The report outlines the geographical segmentation of this market with individual countries split under each region of the Americas, and the EMEA and APAC regions. Further, the report mention segmentation of market based on application and its forecast during 2014-2019. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Bio-Rad Laboratories
• Maxcyte
• Polyplus Transfection
• Promega
• Thermo Fisher Scientific
Other Prominent Vendors
• Affymetrix
• Agilent Technologies
• Altogen Biosystems
• Boca Scientific
• Chemicell
• Clontech
• CytoPulse
• Deliverics
• GE Lifesciences
• IBA GmbH
• Inovio Pharmaceuticals
• Lonza
• Merck KGaA
• Miltenyi Biotec
• Mirus Bio
• nanoTherics
• Origene
• Oz Biosciences
• Promokine
• Qiagen
• SignaGen
• Synvolux therapeutics
• Thermo Scientific Bio
Market Driver
• Demand for Products Enabling Stable Transfection
• For a full, detailed list, view our report
Market Challenge
• Cost of Transfection Reagents
• For a full, detailed list, view our report
Market Trend
• Innovations in Transfection Technology
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview of Transfection Technology
06.1 Applications of Transfection Technology
06.1.1 Transfer of Cloned Genes
06.1.2 Transfer of RNA
06.1.3 Study of Nucleic Acid
06.2 Factors Determining Optimal Transfection Methods
06.2.1 Choice of Reagent
06.2.2 Type of Molecule Transfected
06.3 Factors Influencing Transfection Efficiency
06.3.1 Cell Health & Cell Culture
06.3.2 Cell Confluency
06.3.3 DNA Quality and Quantity
06.3.4 Media formulation
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Methods
08.1 Carrier Molecule Based Method
08.1.1 Calcium phosphate co-precipitation
08.1.2 Cationic lipids: Liposomes
08.1.3 Cationic polymers
08.2 Direct Delivery Based Method
08.2.1 Gene gun
08.2.2 Electroporation
08.2.3 Optoinjection
08.2.4 Magnet mediated transfection
08.3 Transfection using Viral Vectors
08.4 Global Transfection Technology Market by Methods 2014-2019
08.5 Global Carrier Molecule Based Method Market
08.5.1 Market Size and Forecast
08.6 Global Direct Delivery Based Method Market
08.6.1 Market Size and Forecast
08.7 Global Viral Vector Based Method Market
08.7.1 Market Size and Forecast
09. Geographical Segmentation
09.1 Global Transfection Technology Market by Geographical Segmentation 2014-2019
09.2 Transfection Technology Market in the Americas
09.2.1 Market Size and Forecast
09.3 Transfection Technology Market in the EMEA Region
09.3.1 Market Size and Forecast
09.4 Transfection Technology Market in the APAC Region
09.4.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
11.1 Demand for Products Enabling Stable Transfection
11.2 Increased Understanding of Genetic Disorders
11.3 Increased Collaborations
12. Drivers and their Impact
13. Market Challenges
13.1 Cost of Transfection Reagents
13.2 Cytotoxicity to the Cells by the Reagents
13.3 Non uniformity of Protocol
14. Impact of Drivers and Challenges
15. Market Trends
15.1 Innovations in Transfection Technology
15.2 Increased usage of "one- stop solutions"
15.3 Online Sales
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Bio-Rad Laboratories Inc.
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Business Segmentation
18.1.4 Business Strategy
18.1.5 Revenue by Business Segmentation
18.1.6 Revenue Comparison 2011 and 2012
18.1.7 Revenue by Geographical Segmentation
18.1.8 Key Information
18.1.9 SWOT Analysis
18.2 MaxCyte
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Product and Service Segmentation
18.2.4 Recent Developments
18.2.5 SWOT Analysis
18.3 Polyplus transfection
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Transfection Reagents Segmentation
18.3.4 Recent Developments
18.3.5 SWOT Analysis
18.4 Promega
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Products and Services
18.4.4 Recent Developments
18.4.5 SWOT Analysis
18.5 Thermo Fisher
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation
18.5.4 Business Segmentation by Revenue
18.5.5 Product Segmentation by Revenue
18.5.6 Geographical Segmentation by Revenue 2013
18.5.7 Business Strategy
18.5.8 Key Information
18.5.9 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Transfection Technology Market 2014- 2019 (US$ million)
Exhibit 3: Classification of Transfection Methods
Exhibit 4: Classification of Carrier Molecule Based Method
Exhibit 5: Classification of Direct Delivery Based Method
Exhibit 6: Segmentation of the Global Transfection Technology Market 2014-2019 (US$ million)
Exhibit 7: Segmentation of the Global Transfection Technology Market Share 2014-2019
Exhibit 8: Global Carrier Molecule Based Method Market 2014-2019 (US$ million)
Exhibit 9: Global Direct Delivery Based Method Market 2014-2019 (US$ million)
Exhibit 10: Global Viral Vector Based Method Market 2014-2019 (US$ million)
Exhibit 11: Geographical Segmentation of Global Transfection Technology Market by Value 2014-2019 (US$ million)
Exhibit 12: Geographical Segmentation of Global Transfection Technology Market Share 2014-2019 (US$ million)
Exhibit 13: Transfection Technology market in the Americas 2015-2019 (US$ million)
Exhibit 14: Estimated U.S. Research and Development Expenses (US$ million)
Exhibit 15: Transfection Technology market in the EMEA 2015-2019 (US$ million)
Exhibit 16: Transfection Technology market in the APAC 2015-2019 (US$ million)
Exhibit 17: Bio-Rad Laboratories Inc.: Business Segmentation
Exhibit 18: Bio-Rad Laboratories Inc.: Revenue by Business Segmentation 2012
Exhibit 19: Bio-Rad Laboratories Inc.: Revenue Comparison by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 20: Bio-Rad Laboratories Inc.: Revenue by Geographical Segmentation 2012
Exhibit 21: MaxCyte : Product and Service Segmentation 2013
Exhibit 22: Polyplus transfection : Transfection Reagents Segmentation
Exhibit 23: Promega: Key Products and Services
Exhibit 24: Thermo Fisher: Business Segmentation
Exhibit 25: Thermo Fisher: Business Segmentation by Revenue 2013
Exhibit 26: Thermo Fisher: Product Segmentation by Revenue 2013
Exhibit 27: Thermo Fisher: Geographical Segmentation by Revenue 2013
